| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/12/2009 | US20090068278 Use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
| 03/12/2009 | US20090068277 Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom |
| 03/12/2009 | US20090068276 Pharmaceutical compositions |
| 03/12/2009 | US20090068275 Process for the Manufacture of Powders of Inhalable Medicaments |
| 03/12/2009 | US20090068274 Highly efficient delivery of a large therapeutic mass aerosol |
| 03/12/2009 | US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt |
| 03/12/2009 | US20090068272 Mesoporous calcium silicate compositions and methods for synthesis of mesoporous calcium silicate for controlled release of bioactive agents |
| 03/12/2009 | US20090068271 Embolization particles |
| 03/12/2009 | US20090068270 Treatment of degenerated disc with autologous cells |
| 03/12/2009 | US20090068269 Orally adminstrable opioid formulations having extended duration of effect |
| 03/12/2009 | US20090068268 Melt granulation of a composition containing a calcium-containing compound |
| 03/12/2009 | US20090068267 Novel Pharmaceutical Compositions |
| 03/12/2009 | US20090068266 Sirolimus having specific particle size and pharmaceutical compositions thereof |
| 03/12/2009 | US20090068265 Ecklonia cava extracts for alleviating or preventing asthmatic reactions |
| 03/12/2009 | US20090068264 Clinical Applications of Tetrahydrobiopterin, Lipoic Acid and Their Salts and Methods of Preparing Tetrahydrobiopterin Bis-Lipoate |
| 03/12/2009 | US20090068263 Multiple unit compositions |
| 03/12/2009 | US20090068262 Rapid dissolution of combination products |
| 03/12/2009 | US20090068261 Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles |
| 03/12/2009 | US20090068260 Beta-1-selective adrenoceptor blocking agent compositions and methods for their preparation |
| 03/12/2009 | US20090068259 Controlled Surface Gelling of Mucoadhesive Polymers on Oral Mucosa |
| 03/12/2009 | US20090068258 Caveolin-mimetic peptide for prevention and treatment of pulmonary hypertension and right ventricular hypertrophy |
| 03/12/2009 | US20090068257 Betulonic and betulinic acid derivatives |
| 03/12/2009 | US20090068256 Encapsulation of Bioactive Complexes in Liposomes |
| 03/12/2009 | US20090068255 Use of matrix metalloproteinase inhibitors in skin care |
| 03/12/2009 | US20090068254 Multivalent liposomal vaccine compositions comprising polysaccharide antigens and a protein adjuvant |
| 03/12/2009 | US20090068253 Method for the treatment of infection with hhv-6 virus and the amelioration of symptoms related to virus using liposomal encapsulation for delivery of reduced glutathione |
| 03/12/2009 | US20090068252 Transdermal Absorption Preparation |
| 03/12/2009 | US20090068243 Novel formulations for delivery of antiviral peptide therapeutics |
| 03/12/2009 | US20090068239 Refreshment towel and applied solution |
| 03/12/2009 | US20090068237 Dry eye treatment |
| 03/12/2009 | US20090068236 Oral Cephalotaxine Dosage Forms |
| 03/12/2009 | US20090068151 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 03/12/2009 | US20090068125 Treatment for mucositis |
| 03/12/2009 | US20090068118 Device for delivery of a foamable composition |
| 03/12/2009 | US20090068117 Stay-on selenium foam |
| 03/12/2009 | US20090068115 Amine Functionalized Superparamagnetic Nanoparticles for the Synthesis of Bioconjugates and Uses Therefor |
| 03/12/2009 | US20090068106 selectively inhibit alpha v beta 3 integrin; used in the treatment of diseases associated with angiogenesis and cancer |
| 03/12/2009 | US20090068094 Inhibitors of endo-exonuclease activity for treating cancer |
| 03/12/2009 | CA2714921A1 Pharmaceutical compositions |
| 03/12/2009 | CA2699671A1 Improved liposomes and uses thereof |
| 03/12/2009 | CA2699172A1 Compositions and methods for delivery of poorly soluble drugs |
| 03/12/2009 | CA2698683A1 Dheas inhalation compositions |
| 03/12/2009 | CA2698661A1 Method to ameliorate oxidative stress and improve working memory via pterostilbene administration |
| 03/12/2009 | CA2698498A1 Antiviral topical formulations in the form of a bio-adhesive gel |
| 03/12/2009 | CA2697886A1 Method and composition for making an orally disintegrating dosage form |
| 03/12/2009 | CA2697496A1 Controlled release azithromycin solid dosages forms |
| 03/11/2009 | EP2033934A1 Hollow-fiber-like organic nanotube and process for production thereof |
| 03/11/2009 | EP2033653A1 A chinese medicine composition and preparation method and use thereof |
| 03/11/2009 | EP2033649A1 Pharmaceutical composition for treatment of ocular hypertension |
| 03/11/2009 | EP2033648A2 Sustained release drug delivery system containing codrugs |
| 03/11/2009 | EP2033643A1 Compressed preparation |
| 03/11/2009 | EP2033633A2 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure |
| 03/11/2009 | EP2033631A2 Pravastatin pharmaceutical formulations and methods of their use |
| 03/11/2009 | EP2033630A1 A novel controlled release-niacin formulation |
| 03/11/2009 | EP2033629A1 Solid pharmaceutical composition comprising valsartan |
| 03/11/2009 | EP2033620A1 Formulation of natural triterpenes and biophenols obtained from the genus olea in liposomes |
| 03/11/2009 | EP2033619A1 Method for dispersing ionic nanoparticles |
| 03/11/2009 | EP2033616A1 Method of producing nanoparticle dispersion of medicinal component |
| 03/11/2009 | EP2032652A2 Crosslinked, degradable polymers and uses thereof |
| 03/11/2009 | EP2032208A1 System and method for promoting intrinsic conduction through atrial timing |
| 03/11/2009 | EP2032139A2 Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
| 03/11/2009 | EP2032137A2 Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| 03/11/2009 | EP2032129A2 Compositions of phenylephrine useful for treatment of respiratory illness |
| 03/11/2009 | EP2032126A2 Rabeprazole formulation |
| 03/11/2009 | EP2032125A2 Ropinirole-containing pharmaceutical compositions in the form of a gel, uses thereof |
| 03/11/2009 | EP2032124A1 Multiparticulate osmotic delivery system |
| 03/11/2009 | EP2032123A1 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
| 03/11/2009 | EP2032101A2 Punctal plugs for the delivery of active agents |
| 03/11/2009 | EP2032100A2 Punctal plugs for the delivery of active agents |
| 03/11/2009 | EP2031981A2 Method and microcapsules for improving organoleptic properties |
| 03/11/2009 | EP1951232A4 Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms |
| 03/11/2009 | EP1904099B1 Thermoreversible immuno- adjuvant emulsion |
| 03/11/2009 | EP1888027B1 Medicated product for local use based on natural materials |
| 03/11/2009 | EP1791643B1 Multi-cap reservoir devices for controlled release or exposure of reservoir contents |
| 03/11/2009 | EP1786400B1 Pharmaceutical compositions for controlled release delivery of biologically active compounds |
| 03/11/2009 | EP1773292B1 Rapidly disintegrating orodispersible composition containing nonfilamentous coprocessed polyols particles and silicified microcrystalline cellulose |
| 03/11/2009 | EP1691824B1 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 03/11/2009 | EP1680097B1 Preparations for topical application and methods of delivering an active agent to a substrate |
| 03/11/2009 | EP1641463B1 Compositions in the form of a spray comprising a pharmaceutical agent at least one volatile silicone and a non-volatile oily phase |
| 03/11/2009 | EP1534202B1 Ophthalmic drug delivery system |
| 03/11/2009 | EP1524981B1 Sustained release formulations comprising lamotrigine |
| 03/11/2009 | EP1516624B1 Method of producing calcium gluconolactate, compositions, processes and uses of same |
| 03/11/2009 | EP1468085B1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis |
| 03/11/2009 | EP1460992B1 Stabilized reverse micelle compositions and uses thereof |
| 03/11/2009 | EP1411899B1 Taste masking composition |
| 03/11/2009 | EP1337237B1 Pharmaceutical preparations comprising corticosteroids and antiinfective agents |
| 03/11/2009 | EP1326586B1 New pharmaceutical compositions containing epinastine and pseudoephedrine |
| 03/11/2009 | EP1318801B1 Topical analgesic compositions containing aliphatic polyamines and methods of using same |
| 03/11/2009 | EP1313451B1 Milled particles |
| 03/11/2009 | EP1292639B1 Highly flexible starch-based films |
| 03/11/2009 | EP1239938B1 Method for capturing fine particles by percolation in a bed of granules |
| 03/11/2009 | EP1137403B1 Sustained release tablet containing hydrocolloid and cellulose ether |
| 03/11/2009 | EP1067913A4 Compositions and methods of adjusting steroid hormone metabolism through facilitated absorption of hydrophobic dietary compounds |
| 03/11/2009 | EP0988374B1 Hydrophilic composition containing protease produced by vibrio proteolyticus |
| 03/11/2009 | EP0847242B2 Sugar-free dragee-like products |
| 03/11/2009 | CN101384297A Iontophoretic transdermal delivery of nicotine salts |
| 03/11/2009 | CN101384281A Granules, tablets and metuod of producing the same |
| 03/11/2009 | CN101384253A Disinfectant ointment |
| 03/11/2009 | CN101384252A Chewable capsules |
| 03/11/2009 | CN101384251A Solid preparation containing an insulin sensitizer |